{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-048576","form_type":"8-K","ticker":"BCYC","cik":"0001761612","company_name":"BICYCLE THERAPEUTICS PLC","filed_at":"2024-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.950727+00:00","generated_at":"2026-06-03T19:12:06.499163+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bicycle Therapeutics appoints Felix Baker to board; Jordan resigns, becomes consultant","bullets":["Veronica Jordan resigned as director April 17; will serve as consultant at GBP 12,000/yr for 2-year term, equity continues vesting.","Felix J. Baker appointed as Class I director effective April 18; will sit on Nominating and Scientific committees.","BBA Funds (Baker's affiliates) obtained registration rights for resale of ordinary shares/ADSs; company to file registration within 60 days of demand.","BBA Funds hold >10% of outstanding shares; Baker is a managing member of Baker Bros. Advisors GP."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-048576","json":"https://secwatch.observer/filing/0001104659-24-048576.json","markdown":"https://secwatch.observer/filing/0001104659-24-048576.md","text":"https://secwatch.observer/filing/0001104659-24-048576.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924048576/0001104659-24-048576-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924048576/tm2412008d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T19:12:06.499163+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5a4c9e250e","claim":"Felix J. Baker was appointed as Class I Director at BICYCLE THERAPEUTICS PLC.","evidence_excerpt":"On April 16, 2024, the Board , upon the recommendation of the Nominating and Corporate Governance Committee of the Company (the “ NCGC ”), appointed Felix J. Baker, Ph.D. to the Board, effective as of April 18, 2024, New York City time.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924048576/0001104659-24-048576-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"},{"claim_id":"71b1d7932c","claim":"Veronica Jordan resigned as Class I Director at BICYCLE THERAPEUTICS PLC.","evidence_excerpt":"On April 16, 2024, Veronica Jordan, Ph.D. notified the Board of Directors of the Company (the “ Board ”) of her decision to resign as a Class I director of the Company and as the Chair of the Compensation Committee of the Board and as a member of the Audit Committee of the Board, effective as of the close of business on April 17, 2024, New York City time.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465924048576/0001104659-24-048576-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}